Clinical Trials Sponsored by Mercy Research

Total 44360 results

Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Dwarfism, Pituitary
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

Neuropathic Pain Management (M-F0434)

Diabetic Neuropathies | Polyneuropathies

Mexico
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Terminated

Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants (SPET)

Non-obstructive Coronary Artery Disease

China
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Terminated

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants (Biso-CHF)

Heart Failure

China
Merck KGaA, Darmstadt, Germany
Merck spol. s r.o., Slovakia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia (ECOS SVK)

Growth Disorders

Slovakia
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico (ECOS MEX)

Growth Disorders

Mexico
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Hypertension

China
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (ReNew)

Multiple Sclerosis

Australia
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Terminated

Colposeptine for the Treatment of Bacterial Vaginosis

Vaginosis, Bacterial

China
EMD Serono Research & Development Institute, Inc.
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Terminated

Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

United States, France, Belgium, Spain, Russian Federation, Italy
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease (RESPOND)

Non-Obstructive Coronary Artery Disease

Germany
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia (ECOS AUS)

Growth Disorders

Australia
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina (SIGMART)

Coronary Disease | Stable Angina

China
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Polycystic Ovarian Syndrome | Anovulation | Oligo-ovulation | Hypothalamic-pituitary Dysfunction

Japan
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Non-small Cell Lung Cancer

Germany
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management

Diabetic Peripheral Neuropathic Pain

Mexico
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Infertility | Ovulation Induction

Japan
Cornell University
Children's Mercy Hospital Kansas City

Recruiting

Ovarian Morphology in Girls (OMG)

Amenorrhea | Puberty | Oligomenorrhea

United States
Winston Manimtim

Recruiting

Forced Oscillometry in Infants With Bronchopulmonary Dysplasia

Infant, Premature, Diseases | Respiratory Distress Syndrome | Bronchopulmonary Dysplasia

United States
Sisters of Mercy University Hospital
BioGaia AB

Unknown

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children

Abdominal Pain | Constipation - Functional

Croatia
Orthopaedic Associates of Michigan, PC
Mercy Health

Recruiting

Irrisept C.Acnes Study

Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty

United States
Lori Erickson

Enrolling by invitation

CHAMP App Cardiac Study and Repository (CHAMP)

Heart Defects, Congenital | Pediatrics

United States
Children's Mercy Hospital Kansas City
Gabi SmartCare

Enrolling by invitation

WIReD: Wireless Interstage Remote Device Study (WIReD)

Pediatrics | Congenital Heart Disease in Children | Vital Signs | Remote Monitoring

United States
Mercy Health Ohio
St. Elizabeth Youngstown Hospital

Completed

Spiritual Flow and Nurse Wellbeing

Burnout, Professional

United States
Children's Mercy Hospital Kansas City
Genentech, Inc.

Completed

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Growth Hormone Deficiency

United States
Children's Mercy Hospital Kansas City
Children's Hospital Colorado; St. Jude Children's Research Hospital; Nationwide...

Withdrawn

Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients

Stem Cell Transplant Complications | Bone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, Hepatic

United States
Mercy Health Ohio
Northeast Ohio Medical University

Recruiting

Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting

Urinary Tract Infections

United States
Children's Mercy Hospital Kansas City
Medtronic - MITG

Completed

Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children (CE)

IBD

United States
Children's Mercy Hospital Kansas City
VSL Pharmaceuticals

Completed

Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease

Crohn's Disease

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany

Completed

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Relapsing-Remitting Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Completed

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Relapsing Multiple Sclerosis (RMS)

Bulgaria, Poland, Argentina, Hungary, Korea, Republic of, Saudi Arabia, Egypt, Algeria, Bahrain, Iran, Islamic Republic of, Kuwait, Lebanon, Morocco
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Terminated

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Infertility | Fertility | Follicle Stimulating Hormone Deficiency

United Arab Emirates
European Organisation for Research and Treatment...
Merck KGaA, Darmstadt, Germany

Recruiting

Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (RAVINA)

Locally Advanced Head and Neck Squamous Cell Carcinoma

France, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
Harry H Yoon
Mayo Clinic; Merck Sharp & Dohme LLC

Recruiting

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL)

Adenocarcinoma | Gastric Cancer | GastroEsophageal Cancer

United States
University of Florida
Patient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVie

Completed

Study of Oral Treatments for Hepatitis C (PRIORITIZE)

Chronic Hepatitis C

United States
Professor Saad Shakir
Merck Sharp & Dohme LLC

Completed

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

Bipolar I Disorder

United Kingdom
Institute Of Cardiology & Internal Diseases, Kazakhstan
Merck Sharp & Dohme LLC; Synergy Research Group

Unknown

Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

Metabolic Syndrome | Fibrosis, Liver | Cirrhoses, Liver | Chronic Hepatitis C Genotype 1B

Kazakhstan
Community Research Initiative of New England
Bristol-Myers Squibb; Merck Sharp & Dohme LLC

Completed

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. (BATAR)

HIV

United States
European Organisation for Research and Treatment...
Merck KGaA, Darmstadt, Germany

Terminated

Colorectal Cancer (CRC) Cetuximab Elderly Frail

Colorectal Cancer Metastatic

Cyprus, Belgium, Spain
Diwakar Davar
Merck Sharp & Dohme LLC; Gateway for Cancer Research

Not yet recruiting

Pembrolizumab/Lenvatinib With and Without Responder-derived FMT in Relapsed/Refractory Melanoma

PD-1 Refractory Advanced Melanoma

United States
European Organisation for Research and Treatment...
Merck Sharp & Dohme LLC

Completed

Pembrolizumab in Untreated Extensive SCLC (REACTION)

Small Cell Lung Cancer (SCLC)

United Kingdom, France, Italy
Nisha Mohindra, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network; Celgene Corporation

Terminated

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Non-Small Cell Lung Cancer

United States
National Opinion Research Center
Merck Sharp & Dohme LLC; Emory University; Grady Health System

Terminated

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital (EZ-C)

Hepatitis C

United States
The HIV Netherlands Australia Thailand Research...
Merck Sharp & Dohme LLC; Chulalongkorn University

Unknown

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Compensated Cirrhosis

Thailand
Kirby Institute
Merck Sharp & Dohme LLC; amfAR, The Foundation for AIDS Research; Abbott

Completed

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen (SECOND-LINE)

HIV Infections

Taiwan, Australia, Argentina, Singapore, India, France, South Africa, Chile, Germany, Hong Kong, Ireland, Malaysia, Mexico, New Zealand, Nigeria, Peru, United Kingdom
Pancreatic Cancer Research Team
Merck Sharp & Dohme LLC; University of Washington; Halozyme Therapeutics

Unknown

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma

United States
University of Calgary
Merck Sharp & Dohme LLC; Canadian Institutes of Health Research (CIHR)

Completed

Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins (PAFRIOSIES)

Atrial Fibrillation

Canada
Baylor College of Medicine
Merck Sharp & Dohme LLC; The Methodist Hospital Research Institute

Recruiting

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Arkadiusz Z. Dudek, MD
Merck Sharp & Dohme LLC; Big Ten Cancer Research Consortium

Completed

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Clear Cell Renal Carcinoma

United States
Professor Saad Shakir
Merck Sharp & Dohme LLC

Completed

Observational Post-Authorisation Safety Study of Asenapine (Sycrest) (OBSERVA)

Manic Disorder

United Kingdom

Clinical Trials Sponsored by Mercy Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations